In fiscal year 2025 AstraZeneca reported $58.7B in revenue against Bristol Myers Squibb's $48.2B, 1.22× as much.
| Measure | AZN | BMY | Gap |
|---|---|---|---|
| Revenue | $58.7B | $48.2B | ×1.22 |
| Gross profit | $48.1B | $30.7B | ×1.56 |
| Cost of revenue | $10.6B | $13.9B | ×1.31 |
| Operating income | $13.7B | $9.3B | ×1.47 |
| Net income | $10.2B | $7.1B | ×1.45 |
| EPS (diluted) | 6.54 | 3.46 | ×1.89 |
| Total assets | $114B | $90.0B | ×1.27 |
| Total liabilities | $65.4B | $71.5B | ×1.09 |
| Shareholders' equity | $48.7B | $18.5B | ×2.63 |
| Cash | $5.7B | $10.2B | ×1.79 |
| Long-term debt | $24.7B | $42.9B | ×1.73 |
| Net margin | 17.4% | 14.6% | ×1.19 |
| Operating margin | 23.4% | 19.4% | ×1.21 |
| Operating cash flow | $14.6B | $14.2B | ×1.03 |
| Capital expenditure | $2.8B | $1.3B | ×2.14 |
| Free cash flow | $11.8B | $12.8B | ×1.09 |
| R&D expense | $14.2B | $10.0B | ×1.43 |
| Dividends paid | $5.0B | $5.0B | ×1.01 |
| Income tax expense | $2.2B | $2.3B | ×1.05 |
| Share buybacks | $521M | $0 | — |
The larger of the two figures is in bold. Larger is not automatically better: on debt, cost and tax a bigger number is simply a bigger number. This site reports the figures and leaves the judgement to you.
Revenue, year by year
AstraZeneca · 2015–2025
Bristol Myers Squibb · 2016–2025
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=AstraZeneca vs Bristol Myers Squibb |url=https://companiesranked.com/en/compare/astrazeneca-vs-bristol-myers-squibb |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). AstraZeneca vs Bristol Myers Squibb. CompaniesRanked. https://companiesranked.com/en/compare/astrazeneca-vs-bristol-myers-squibbBibTeX
@misc{companiesranked-en-compare-astrazeneca-vs-bristol-myers-squibb-2026,
author = {{CompaniesRanked}},
title = {{AstraZeneca vs Bristol Myers Squibb}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/compare/astrazeneca-vs-bristol-myers-squibb}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.